Cargando…

Echocardiography in cardioembolic stroke prevention

Stroke is a leading cause of mortality and disability, and cardiac embolism accounts for one-third of all ischaemic strokes. Thirty per cent of strokes are cryptogenic. In this setting, echocardiography is essential in the diagnosis, treatment, and prevention of embolic stroke of undetermined source...

Descripción completa

Detalles Bibliográficos
Autores principales: Canali, Emanuele, Serani, Marco, Tarzia, Pierpaolo, Ciampi, Pellegrino, Canestrelli, Stefano, Calò, Leonardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132583/
https://www.ncbi.nlm.nih.gov/pubmed/37125319
http://dx.doi.org/10.1093/eurheartjsupp/suad022
_version_ 1785031413275295744
author Canali, Emanuele
Serani, Marco
Tarzia, Pierpaolo
Ciampi, Pellegrino
Canestrelli, Stefano
Calò, Leonardo
author_facet Canali, Emanuele
Serani, Marco
Tarzia, Pierpaolo
Ciampi, Pellegrino
Canestrelli, Stefano
Calò, Leonardo
author_sort Canali, Emanuele
collection PubMed
description Stroke is a leading cause of mortality and disability, and cardiac embolism accounts for one-third of all ischaemic strokes. Thirty per cent of strokes are cryptogenic. In this setting, echocardiography is essential in the diagnosis, treatment, and prevention of embolic stroke of undetermined source since it is a widely available, safe, and inexpensive tool. Transthoracic echocardiography and transoesophageal echocardiography, furthermore, are proven to change therapeutic management leading to initiation of anti-coagulation, anti-microbial therapy, patent foramen ovale (PFO) closure, or cardiac tumour resection. The most common cardioembolic sources include left atrial appendage thrombus, left ventricular thrombus, vegetations in endocarditis, paradoxical embolization in PFO, prosthesis thrombosis, and intracardiac tumours. Although the presence of a cardioembolic source only represents a risk factor for an ischaemic stroke, it could not assure the certain or the unique cause of the event. The purpose of this review is to underline the importance of echocardiography and overview the main sources of cardiac embolism and the echocardiographic features.
format Online
Article
Text
id pubmed-10132583
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-101325832023-04-27 Echocardiography in cardioembolic stroke prevention Canali, Emanuele Serani, Marco Tarzia, Pierpaolo Ciampi, Pellegrino Canestrelli, Stefano Calò, Leonardo Eur Heart J Suppl PLACE 2022 Supplement Paper Stroke is a leading cause of mortality and disability, and cardiac embolism accounts for one-third of all ischaemic strokes. Thirty per cent of strokes are cryptogenic. In this setting, echocardiography is essential in the diagnosis, treatment, and prevention of embolic stroke of undetermined source since it is a widely available, safe, and inexpensive tool. Transthoracic echocardiography and transoesophageal echocardiography, furthermore, are proven to change therapeutic management leading to initiation of anti-coagulation, anti-microbial therapy, patent foramen ovale (PFO) closure, or cardiac tumour resection. The most common cardioembolic sources include left atrial appendage thrombus, left ventricular thrombus, vegetations in endocarditis, paradoxical embolization in PFO, prosthesis thrombosis, and intracardiac tumours. Although the presence of a cardioembolic source only represents a risk factor for an ischaemic stroke, it could not assure the certain or the unique cause of the event. The purpose of this review is to underline the importance of echocardiography and overview the main sources of cardiac embolism and the echocardiographic features. Oxford University Press 2023-04-26 /pmc/articles/PMC10132583/ /pubmed/37125319 http://dx.doi.org/10.1093/eurheartjsupp/suad022 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle PLACE 2022 Supplement Paper
Canali, Emanuele
Serani, Marco
Tarzia, Pierpaolo
Ciampi, Pellegrino
Canestrelli, Stefano
Calò, Leonardo
Echocardiography in cardioembolic stroke prevention
title Echocardiography in cardioembolic stroke prevention
title_full Echocardiography in cardioembolic stroke prevention
title_fullStr Echocardiography in cardioembolic stroke prevention
title_full_unstemmed Echocardiography in cardioembolic stroke prevention
title_short Echocardiography in cardioembolic stroke prevention
title_sort echocardiography in cardioembolic stroke prevention
topic PLACE 2022 Supplement Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132583/
https://www.ncbi.nlm.nih.gov/pubmed/37125319
http://dx.doi.org/10.1093/eurheartjsupp/suad022
work_keys_str_mv AT canaliemanuele echocardiographyincardioembolicstrokeprevention
AT seranimarco echocardiographyincardioembolicstrokeprevention
AT tarziapierpaolo echocardiographyincardioembolicstrokeprevention
AT ciampipellegrino echocardiographyincardioembolicstrokeprevention
AT canestrellistefano echocardiographyincardioembolicstrokeprevention
AT caloleonardo echocardiographyincardioembolicstrokeprevention